2026 NPPES data Colon & Rectal Surgery Physician NPI 1861492191 MD
Verify on CMS →

Mark Blankenship, MD

Colon & Rectal Surgery Physician in Rincon, Georgia.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,642 in Colon & Rectal Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
375
Medicare Part D claims · 147 beneficiaries · Colon & Rectal Surgery Physician avg: 210
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$64.48
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Mark Blankenship, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 375 Medicare Part D claims in 2024.

75/100
CMS neutral score · not measured
375
Part D claims, 2024
Likely
board-certified (heuristic)
≥56th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Mark Blankenship, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1861492191), first enumerated 07/28/2005.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 375 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $64.48 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1861492191 · Colon & Rectal Surgery Physician

NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-NEUTRAL · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1861492191
  • ENUM-LEGACY 2005
  • TAX-NARROW 1,642
  • MIPS-NEUTRAL 75/100
  • RX-LIGHT 375
  • BOOK-THIN 56 in Georgia
  • PHOTO-ENUM Charles Taylor · 2005

Mark Blankenship, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

375 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). This entry sits in this band. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Mark Blankenship, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Mark Blankenship, MD?

CMS neutral score, not measured

NPI registry status

Active

Issued 07/28/2005

NPI 1861492191

Primary specialty

Colon & Rectal Surgery Physician

Niche

1,642 US NPIs in this specialty

Medicare Part D claims

375 79% vs specialty avg

2024 prescription claims

Specialty avg: 210

MIPS final score

75/100

CMS neutral score, not measured

No category scores published; CMS assigned the performance threshold

Specialty distribution in Georgia

How Colon & Rectal Surgery Physician compares to other specialties among Georgia providers

Georgia providers
Behavior Technician7.5%Student in an Organized Heal…5%Pharmacist5%Family Nurse Practitioner4.8%Physical Therapist3.9%Professional Counselor3.6%Colon & Rectal Surgery Physi…0%
Largest specialties in Georgia (% of in-state providers)

MIPS score not measured

CMS assigned a neutral 75/100 threshold

CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

594 S COLUMBIA AVE
Rincon, GA 31326

Provider Details

NPI 1861492191
Specialty Colon & Rectal Surgery Physician
Credentials MD
Gender Male
NPI Issued 07/28/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
CMS neutral threshold · not measured

Reporting: Group practice

Hospital and facility affiliations

Facilities where Mark Blankenship, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Metro Surgical PC
Bluffton, SC
Sjc MS General Surgery LLC
Rincon, GA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Blankenship, MD. Source: openpaymentsdata.cms.gov.

Total received

$64

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

375
Total Claims
$456K
Total Drug Cost
147
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
379.4
Total Day Supply
3,080
Generic Drug Cost
$4K
Opioid Claims
89 (23.7% rate)
Antibiotic Claims
144

Patient Demographics

Average Patient Age
71.6 years
Avg HCC Risk Score
1.53
Gender Split
59% female / 41% male
Age Distribution
<65: 17, 65-74: 82, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Mark Blankenship, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
70
Metronidazole
63
Neomycin Sulfate
56
Sod Sulf-Potass Sulf-Mag Sulf
Sodium, Potassium,mag Sulfates
32
Ondansetron Hcl
18
Ciprofloxacin Hcl
14
Suprep
Sodium, Potassium,mag Sulfates
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Colon & Rectal Surgery Physician Overview

How Mark Blankenship, MD fits within the Colon & Rectal Surgery Physician landscape nationally.

1,642
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
210
Avg Claims per Provider

Mark Blankenship, MD's 375 claims are above the specialty average of 210.

Nationwide Colon & Rectal Surgery Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Blankenship, both outside Georgia so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (75 here).

Same NPPES enumeration year (2005)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Colon & Rectal Surgery Physician Providers in Georgia

Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Blankenship.

One of 56 Colon & Rectal Surgery Physician providers enrolled in Georgia, 5 are shown here.

Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Mark Blankenship, MD's specialty?
Mark Blankenship, MD specializes in Colon & Rectal Surgery Physician and practices in Rincon, Georgia. Credentials: MD.
How much does Mark Blankenship, MD prescribe under Medicare Part D?
In 2024, Mark Blankenship, MD wrote 375 Medicare Part D claims totaling $456K in drug costs for 147 beneficiaries.
What is Mark Blankenship, MD's Medicare quality score?
Mark Blankenship, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Blankenship, MD located?
Mark Blankenship, MD is located at 594 S COLUMBIA AVE, Rincon, GA, 31326. Phone: (912) 826-4057.
What is Mark Blankenship, MD's NPI number?
Mark Blankenship, MD's National Provider Identifier (NPI) is 1861492191, issued on 07/28/2005.
Does Mark Blankenship, MD prescribe opioids?
Yes, Mark Blankenship, MD had 89 opioid claims in 2024 with an opioid prescribing rate of 23.7%.
How many Colon & Rectal Surgery Physician providers are there in the US?
There are 1,642 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 210 Medicare Part D claims per year.
What drugs does Mark Blankenship, MD prescribe most often?
Based on 2024 Medicare Part D data, Mark Blankenship, MD's most frequently prescribed drugs include Hydrocodone-Acetaminophen, Metronidazole, Neomycin Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Blankenship, MD accept Medicare?
Mark Blankenship, MD appears in CMS Medicare data with 375 Part D claims and 147 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Blankenship, MD's credentials?
Mark Blankenship, MD's NPI is 1861492191 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.